JPWO2022214678A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022214678A5
JPWO2022214678A5 JP2023554016A JP2023554016A JPWO2022214678A5 JP WO2022214678 A5 JPWO2022214678 A5 JP WO2022214678A5 JP 2023554016 A JP2023554016 A JP 2023554016A JP 2023554016 A JP2023554016 A JP 2023554016A JP WO2022214678 A5 JPWO2022214678 A5 JP WO2022214678A5
Authority
JP
Japan
Prior art keywords
protein
positions
fusion
immunogenic composition
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023554016A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024522385A5 (https=
JP2024522385A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/059492 external-priority patent/WO2022214678A2/en
Publication of JP2024522385A publication Critical patent/JP2024522385A/ja
Publication of JP2024522385A5 publication Critical patent/JP2024522385A5/ja
Publication of JPWO2022214678A5 publication Critical patent/JPWO2022214678A5/ja
Pending legal-status Critical Current

Links

JP2023554016A 2021-04-09 2022-04-08 ヒトメタニューモウイルスワクチン Pending JP2024522385A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21167609 2021-04-09
EP21167609.3 2021-04-09
PCT/EP2022/059492 WO2022214678A2 (en) 2021-04-09 2022-04-08 Human metapneumo virus vaccine

Publications (3)

Publication Number Publication Date
JP2024522385A JP2024522385A (ja) 2024-06-19
JP2024522385A5 JP2024522385A5 (https=) 2025-04-15
JPWO2022214678A5 true JPWO2022214678A5 (https=) 2025-04-15

Family

ID=75441775

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023554016A Pending JP2024522385A (ja) 2021-04-09 2022-04-08 ヒトメタニューモウイルスワクチン

Country Status (10)

Country Link
US (2) US20240358812A1 (https=)
EP (2) EP4319804A2 (https=)
JP (1) JP2024522385A (https=)
KR (1) KR20230167017A (https=)
CN (1) CN117279659A (https=)
AU (1) AU2022255923A1 (https=)
BR (1) BR112023017274A2 (https=)
CA (1) CA3210412A1 (https=)
MX (1) MX2023010370A (https=)
WO (2) WO2022214678A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12021552736A1 (en) 2019-05-20 2022-07-11 Valneva Se A subunit vaccine for treatment or prevention of a respiratory tract infection
JP2026504862A (ja) 2023-01-18 2026-02-10 ファイザー・インク 呼吸器疾患に対するワクチン
WO2025119162A1 (zh) * 2023-12-04 2025-06-12 深圳深信生物科技有限公司 偏肺病毒(mpv)疫苗
WO2025126071A1 (en) 2023-12-14 2025-06-19 Pfizer Inc. Rna molecules
WO2026018181A1 (en) 2024-07-17 2026-01-22 Pfizer Inc. Immunogenic compositions and uses thereof
CN119971017B (zh) * 2025-04-16 2025-08-05 北京华诺泰生物医药科技有限公司 一种hmpv疫苗组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547871A (en) 1993-01-25 1996-08-20 American Cyanamid Company Heterologous signal sequences for secretion of insect controlling proteins
ATE509102T1 (de) 1994-07-15 2011-05-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
AT410173B (de) 2000-06-08 2003-02-25 Cistem Biotechnologies Gmbh Antigene zusammensetzung
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
JP4188092B2 (ja) 2001-05-21 2008-11-26 インターツェル・アクチェンゲゼルシャフト 免疫促進性オリゴデオキシ核酸分子
ATE485056T1 (de) 2003-03-24 2010-11-15 Intercell Ag Verbesserte impfstoffe
ES2647882T3 (es) 2011-12-06 2017-12-27 Valneva Austria Gmbh Compuestos de aluminio para su uso en productos terapéuticos y vacunas
EP3236998A1 (en) 2014-12-24 2017-11-01 The U.S.A. as represented by the Secretary, Department of Health and Human Services Recombinant metapneumovirus f proteins and their use
WO2019092002A1 (en) * 2017-11-07 2019-05-16 Valneva Se Pharmaceutical compositions for treatment or prevention of viral infections
PH12021552736A1 (en) * 2019-05-20 2022-07-11 Valneva Se A subunit vaccine for treatment or prevention of a respiratory tract infection

Similar Documents

Publication Publication Date Title
US11998597B2 (en) Vaccine against RSV
US12162909B2 (en) Subunit vaccine for treatment or prevention of a respiratory tract infection
ES3058501T3 (en) Rsv f protein mutants
CA2187083C (fr) Fragment peptidique de la proteine g du virus respiratoire syncytial, agent immunogene, composition pharmaceutique le contenant et procede de preparation
JP7317047B2 (ja) インフルエンザウイルスワクチン及びその使用
WO2020099383A1 (en) Stabilized pre-fusion rsv f proteins
IL200341A (en) Method for the preparation of immunogenic particles containing influenza a m2e protein fused to hepatitis b virus core protein
JPH11508769A (ja) C型肝炎に対するワクチン
KR20230167017A (ko) 인간 메타뉴모 바이러스 백신
JPWO2022214678A5 (https=)
JPH07508520A (ja) 組合せポリペプチド抗原
CN115916237A (zh) 抗病毒病原体的疫苗
JPWO2023096990A5 (https=)
HK40098178A (zh) 人偏肺病毒疫苗
WO2024178371A1 (en) Multicistronic vaccine and methods for producing and using the same
HK40051815A (en) Vaccine against rsv comprising modified f polypeptide
RU2023124900A (ru) Композиции, содержащие адъюванты sbi, и способы их применения
JPWO2023173032A5 (https=)
HK1250939B (en) Vaccine against rsv